Viking Therapeutics, Inc. (VKTX)
36.15
-0.93
(-2.51%)
USD |
NASDAQ |
Dec 15, 16:00
36.24
+0.09
(+0.25%)
After-Hours: 19:06
Viking Therapeutics Research and Development Expense (Annual): 101.64M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 10.99B |
| Pfizer Inc. | 10.74B |
| Amgen, Inc. | 5.676B |
| Altimmune, Inc. | 81.99M |
| Terns Pharmaceuticals, Inc. | 70.11M |